 Pharmaceutical firms pay the majority of these fees, which are used to expedite drug reviews.The FDA's federal budget request for fiscal year (FY) 2008 (October 2007 through September 2008) totaled $2.1 billion, a $105.8 million increase from what it received for fiscal year 2007.In February 2008, the FDA announced that the Bush Administration's FY 2009 budget request for the agency was just under $2.4 billion